Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.678
https://www.valueinhealthjournal.com/article/S1098-3015(13)02583-7/fulltext
Title :
Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02583-7&doi=10.1016/j.jval.2013.08.678
First page :
A441
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
653